|
|||||
|
|
Pharmacodynamics,pharmacokinetics, safety and tolerability of the novel dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1 agonist RG7697 after single subcutaneous administration in healthy subjects |
|
| Authors: | Agnès Portron PharmD Shirin Jadidi MD Neena Sarkar PhD Richard DiMarchi PhD Christophe Schmitt PharmD |
| Affiliation: | 1. Department of Clinical Pharmacology, F. Hoffmann‐La Roche AG, Basel, Switzerland;2. Department of Safety Science, Roche Translational Clinical Research Center, Inc., New York, New York;3. Department of Biostatistics, Roche Translational Clinical Research Center, Inc., New York, New York;4. Department of Chemistry, Novo Nordisk Research Center Indianapolis, Indianapolis, Indiana |
| Abstract: | |
| Keywords: | diabetes dual GIP/GLP‐1 agonist healthy volunteers meal tolerance test NNC0090‐2746 RG7697 RO6811135 single ascending‐dose study |